Search This Blog

Thursday, February 27, 2020

Collegium Pharmaceutical EPS beats by $0.03, beats on revenue

Collegium Pharmaceutical (NASDAQ:COLL): Q4 GAAP EPS of -$0.07 beats by $0.03.
Revenue of $74.2M (+1.0% Y/Y) beats by $0.89M.
Shares +6.55%.
Press Release
https://seekingalpha.com/news/3546744-collegium-pharmaceutical-eps-beats-0_03-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)